Recurrent hepatocellular carcinoma: patterns, detection, staging and treatment

D Papaconstantinou, DI Tsilimigras… - Journal of hepatocellular …, 2022 - Taylor & Francis
Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related deaths
worldwide with the incidence of recurrence being as high as 88% even among patients who …

[HTML][HTML] Ablative strategies for recurrent hepatocellular carcinoma

L Wang, BX Liu, HY Long - World Journal of Hepatology, 2023 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the most common primary liver cancer and is the fifth
leading cause of cancer death worldwide and the third leading cause of all diseases …

Efficacy and safety of TACE combined with lenvatinib and PD‐1 inhibitors for unresectable recurrent HCC: A multicenter, retrospective study

WJ Wang, ZH Liu, K Wang, HM Yu, YQ Cheng… - Cancer …, 2023 - Wiley Online Library
Background There is no consensus on the optimal regimen for unresectable recurrent
hepatocellular carcinoma (HCC), so this retrospective study aimed to evaluate the efficacy …

Repeat hepatectomy versus microwave ablation for solitary and small (≤ 3 cm) recurrent hepatocellular carcinoma with early or late recurrence: A propensity score …

WQ Wang, X Lv, J Li, J Li, JL Wang, T Yuan… - European Journal of …, 2023 - Elsevier
Background Repeat hepatectomy (RH) and microwave ablation (MWA) are frequently used
procedures for the treatment of recurrent hepatocellular carcinoma (HCC) after curative …

Repeat hepatic resection versus percutaneous ablation for the treatment of recurrent hepatocellular carcinoma: meta-analysis

BH Yuan, YK Zhu, XM Zou, HD Zhou, RH Li… - BJS open, 2022 - academic.oup.com
Background The efficacy of repeat hepatic resection (rHR) in the treatment of recurrent
hepatocellular carcinoma compared with radiofrequency or microwave ablation after …

[HTML][HTML] Current status and prospect of treatments for recurrent hepatocellular carcinoma

YQ Yang, ZY Wen, XY Liu, ZH Ma, YE Liu… - World Journal of …, 2023 - ncbi.nlm.nih.gov
Owing to its heterogeneous and highly aggressive nature, hepatocellular carcinoma (HCC)
has a high recurrence rate, which is a non-negligible problem despite the increasing …

Laparoscopic versus open repeat hepatectomy for recurrent hepatocellular carcinoma: a systematic review and meta-analysis of propensity score-matched cohort …

ZQ **ang, FF Zhu, SQ Zhao, HJ Li… - … Journal of Surgery, 2023 - journals.lww.com
Objective: The effectiveness of laparoscopic repeat hepatectomy (LRH) versus open repeat
hepatectomy (ORH) on recurrent hepatocellular carcinoma (RHCC) is unclear. We …

Efficacy and safety of stereotactic body radiotherapy for painful bone metastases: Evidence from randomized controlled trials

Z Wang, L Li, X Yang, H Teng, X Wu, Z Chen… - Frontiers in …, 2022 - frontiersin.org
Background Pain relief is one of the main objectives of radiotherapy for cancer patients with
bone metastases. Stereotactic body radiotherapy (SBRT) enables precise delivery of a …

[HTML][HTML] Salvage locoregional therapies for recurrent hepatocellular carcinoma

CR Criss, MS Makary - World Journal of Gastroenterology, 2023 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the second most common cause of cancer-related death
worldwide. Despite the advent of screening efforts and algorithms to stratify patients into …

Clinical-Radiological Characteristic for Predicting Ultra-Early Recurrence After Liver Resection in Solitary Hepatocellular Carcinoma Patients

X Wang, Y Yu, Y Tao, Y Wang, C Zhang… - Journal of …, 2023 - Taylor & Francis
Objective This study aims to identify independent risk factors for ultra-early recurrence in
patients with early solitary hepatocellular carcinoma (HCC) and develop an individualized …